Contracts › 75F40124C00120
75F40124C00120: Baa-FY24C1IP3-"Defining the Value and Return on Investment of Patient Engagement in Medtech Product Development"
Awarded to The Milken Institute by Food and Drug Administration (FDA).
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40124C00120 |
|---|---|
| Awardee | The Milken Institute |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 813410 Civic and Social Organizations |
| PSC | R499 Support- Professional: Other |
| Place of performance | MD |
| Offers received | 1 |
| Period of performance | 10 September 2024 to 30 November 2026 |
| Potential end | 30 November 2026 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Get new PSC R499 solicitations by email
This contract is coded PSC R499. We'll email you when new PSC R499 (Support- Professional: Other) solicitations post on SAM.gov. The first email lists what is open right now, then at most once a week, only when something new posts. No account needed; unsubscribe in a click.
Going after this work when it recompetes?
- The incumbent's full federal record — every contract, agency and obligation trend in one dossier
- The recompete timeline — period of performance, option years and the estimated solicitation window
- Teaming candidates — the subcontractors already doing this work, and firms ranked by proven work in the same NAICS
- Contracts like this one coming up for recompete, ranked by timing and value (Pro)
Open this contract in FedSift →
Free plan, no credit card.
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 813410 contracts · All expiring contracts · USASpending record